Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various national committee for clinical laboratory standards susceptibility test methods
1994 ◽
Vol 19
(1)
◽
pp. 65-68
◽
1999 ◽
Vol 37
(1)
◽
pp. 279-280
◽
1989 ◽
Vol 27
(1)
◽
pp. 192-195
◽
Keyword(s):
2014 ◽
Vol 2
(4)
◽
pp. 451-459
◽
2004 ◽
Vol 48
(11)
◽
pp. 4457-4459
◽
1996 ◽
Vol 34
(4)
◽
pp. 816-817
◽
1970 ◽
Vol 6
(1)
◽
pp. 121-126
◽
1993 ◽
Vol 31
(9)
◽
pp. 2538-2540
◽
1999 ◽
Vol 123
(7)
◽
pp. 622-625
2001 ◽
Vol 40
(1-2)
◽
pp. 67-70
◽
Keyword(s):